ABOUT COMPANY
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.
|
EARNINGS
Gross Profit (TTM): -12767000
Market Capitalization: 436060000
Operating Margin (TTM): -3.395
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.124
Revenue (TTM): 10538000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.108
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.462
Dividend Date: 2018-05-30
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -23119000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|